InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| VACV-70 | The activation of the adaptor protein STING depends on its interactions with ... | 2024 | Sci Signal | Luteijn R.D. et al. | DOI: 10.1126/scisignal.ade3643 |
| Zeocin® | The activation of the adaptor protein STING depends on its interactions with ... | 2024 | Sci Signal | Luteijn R.D. et al. | DOI: 10.1126/scisignal.ade3643 |
| 2'3'-cGAMP | The activation of the adaptor protein STING depends on its interactions with ... | 2024 | Sci Signal | Luteijn R.D. et al. | DOI: 10.1126/scisignal.ade3643 |
| diABZI (compound 3) | The activation of the adaptor protein STING depends on its interactions with ... | 2024 | Sci Signal | Luteijn R.D. et al. | DOI: 10.1126/scisignal.ade3643 |
| c-di-AMP | The activation of the adaptor protein STING depends on its interactions with ... | 2024 | Sci Signal | Luteijn R.D. et al. | DOI: 10.1126/scisignal.ade3643 |
| Puromycin | Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal... | 2024 | Acta Neuropathol. | Marques C. et al. | DOI: 10.1007/s00401-024-02688-z |
| MycoStrip® - Mycoplasma Detection Kit | Development of New CD38 Targeted Peptides for Cancer Imaging. | 2024 | Mol Imaging Biol. | Zheleznyak A. et al. | DOI: 10.1007/s11307-024-01901-5 |
| LPS-EB (LPS from E. coli O111:B4) | Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibi... | 2024 | Nat Commun. | Nerviani A. et al. | DOI: 10.1038/s41467-024-46564-6 |
| Poly(I:C) (HMW) VacciGrade™ | Abcb10 regulates murine hematopoietic stem cell potential and erythroid diffe... | 2024 | Exp Hematol. | Yahagi A. et al. | DOI: 10.1016/j.exphem.2024.104191 |
| Plasmocin® - Mycoplasma Elimination Reagent | Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. | 2024 | Commun Biol. | Halfmann P.J. et al. | DOI: 10.1038/s42003-024-06015-w |
| G418 (Geneticin) | Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. | 2024 | Commun Biol. | Halfmann P.J. et al. | DOI: 10.1038/s42003-024-06015-w |
| Blasticidin | Treatment with siRNAs is commonly associated with GPX4 up-regulation and targ... | 2024 | Sci Adv. | von Mässenhausen A. et al. | DOI: 10.1126/sciadv.adk7329 |
| QUANTI-Blue™ | Treatment with siRNAs is commonly associated with GPX4 up-regulation and targ... | 2024 | Sci Adv. | von Mässenhausen A. et al. | DOI: 10.1126/sciadv.adk7329 |
| Normocin® - Antimicrobial Reagent | Treatment with siRNAs is commonly associated with GPX4 up-regulation and targ... | 2024 | Sci Adv. | von Mässenhausen A. et al. | DOI: 10.1126/sciadv.adk7329 |
| Poly(I:C) HMW | Treatment with siRNAs is commonly associated with GPX4 up-regulation and targ... | 2024 | Sci Adv. | von Mässenhausen A. et al. | DOI: 10.1126/sciadv.adk7329 |
| Zeocin® | Treatment with siRNAs is commonly associated with GPX4 up-regulation and targ... | 2024 | Sci Adv. | von Mässenhausen A. et al. | DOI: 10.1126/sciadv.adk7329 |
| ODN 2395 - TLR9 ligand | SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Scler... | 2024 | Immunohorizons | Baxter R.M. et al. | DOI: 10.4049/immunohorizons.2300108 |
| Quil-A® adjuvant | In vivo affinity maturation of mouse B cells reprogrammed to express human an... | 2024 | Nat Biomed Eng. | Yin Y. et al. | DOI: 10.1038/s41551-024-01179-6 |
| MPLA Synthetic VacciGrade™ | In vivo affinity maturation of mouse B cells reprogrammed to express human an... | 2024 | Nat Biomed Eng. | Yin Y. et al. | DOI: 10.1038/s41551-024-01179-6 |
| WGP - Whole Glucan Particles | Translational genetics identifies a phosphorylation switch in CARD9 required ... | 2024 | Cell Rep. | Brandt M. et al. | DOI: 10.1016/j.celrep.2024.113944 |